Phase I/II Study of Sorafenib in Combination with Hepatic Arterial Infusion Chemotherapy Using Low-Dose Cisplatin and 5-Fluorouracil

Por Ueshima, Kazuomi, Kudo, Masatoshi, Tanaka, Masatoshi, Kumada, Takashi, Chung, Hobyung, Hagiwara, Satoru, Inoue, Tatsuo, Yada, Norihisa, Kitai, Satoshi
Publicado no Liver Cancer (2015)

Survival Benefit of Locoregional Treatment for Hepatocellular Carcinoma with Advanced Liver Cirrhosis

Por Kitai, Satoshi, Kudo, Masatoshi, Nishida, Naoshi, Izumi, Namiki, Sakamoto, Michiie, Matsuyama, Yutaka, Ichida, Takafumi, Nakashima, Osamu, Matsui, Osamu, Ku, Yonson, Kokudo, Norihiro, Makuuchi, Masatoshi
Publicado no Liver Cancer (2016)

Comparison of systems for assessment of post-therapeutic response to sorafenib for hepatocellular carcinoma

Por Arizumi, Tadaaki, Ueshima, Kazuomi, Takeda, Haruhiko, Osaki, Yukio, Takita, Masahiro, Inoue, Tatsuo, Kitai, Satoshi, Yada, Norihisa, Hagiwara, Satoru, Minami, Yasunori, Sakurai, Toshiharu, Nishida, Naoshi, Kudo, Masatoshi
Publicado no J Gastroenterol (2014)

Effectiveness of Sorafenib in Patients with Transcatheter Arterial Chemoembolization (TACE) Refractory and Intermediate-Stage Hepatocellular Carcinoma

Por Arizumi, Tadaaki, Ueshima, Kazuomi, Minami, Tomohiro, Kono, Masashi, Chishina, Hirokazu, Takita, Masahiro, Kitai, Satoshi, Inoue, Tatsuo, Yada, Norihisa, Hagiwara, Satoru, Minami, Yasunori, Sakurai, Toshiharu, Nishida, Naoshi, Kudo, Masatoshi
Publicado no Liver Cancer (2015)

Unique Association between Global DNA Hypomethylation and Chromosomal Alterations in Human Hepatocellular Carcinoma

Por Nishida, Naoshi, Kudo, Masatoshi, Nishimura, Takafumi, Arizumi, Tadaaki, Takita, Masahiro, Kitai, Satoshi, Yada, Norihisa, Hagiwara, Satoru, Inoue, Tatsuo, Minami, Yasunori, Ueshima, Kazuomi, Sakurai, Toshiharu, Yokomichi, Naosuke, Nagasaka, Takeshi, Goel, Ajay
Publicado em 2013